Citadel Advisors’s VIROPHARMA INC VPHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-34,000
Closed -$1.7M 8304
2013
Q4
$1.7M Buy
34,000
+7,700
+29% +$344K ﹤0.01% 2707
2013
Q3
$1.03M Buy
26,300
+16,400
+166% +$536K ﹤0.01% 3085
2013
Q2
$284K Buy
+9,900
New +$261K ﹤0.01% 4357

Citadel Advisors's VPHM Position: Q1 2014 in Review

Citadel Advisors sold out of VIROPHARMA INC (VPHM) in Q1 2014, closing a stake of 5 shares.

Citadel Advisors first reported a position in VPHM in Q2 2013 and held it in 3 quarters. The position peaked at $50.5M in Q3 2013. 0 funds tracked by Wall St. Rank hold VPHM as of Q1 2014.

  • Citadel Advisors reported no remaining VIROPHARMA INC position as of Q1 2014 after selling out during the quarter.
  • Citadel Advisors sold 5 VIROPHARMA INC shares in Q1 2014.
  • Citadel Advisors first reported a position in VIROPHARMA INC in Q2 2013 and held it in 3 quarters.
  • Citadel Advisors's VIROPHARMA INC position peaked at $50.5M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q1 2014.

Based on Citadel Advisors's 13F filing for Q1 2014, filed 15 May 2014.